The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
ISPP will analyze health systems across states, identifying scalable models and actionable insights to strengthen India's healthcare delivery
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Medical Device Policy is a progressive step in propelling the country towards Atmanirbharta in the heavily import dependent Medical Device Sector
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Today, India stands at 1.7 nurses per 1,000 population, as opposed to the World Health Organization norm of 3 nurses per 1000.
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers
Subscribe To Our Newsletter & Stay Updated
